Where does Roderick Verhelst work?

Roderick Verhelst is Partner at Bioqube Ventures.

What does Roderick Verhelst invest in?

Roderick Verhelst invests in Biotech.

What check size does Roderick Verhelst write?

Roderick Verhelst typically writes checks of $100K – $5M.

Where did Roderick Verhelst go to school?

Roderick Verhelst studied at Solvay Brussels School of Economics and Management (Master of Business Administration (M.B.A.), Business Administration and Management); KU Leuven (Doctor of Philosophy (Ph.D.), Bioscience Engineering); KU Leuven (Master's Degree, Biochemistry).

Roderick Verhelst

Investor

Partner at Bioqube Ventures

Brussels

Writes $100K – $5M checks · typically $1.5M

About

Partner at Bioqube Ventures focused on early-stage therapeutics, who joined in 2022 with over a decade of life science investing experience, previously at PMV where he helped form, finance and exit startups such as GST, Bluebee, Dualyx and Flamingo Therapeutics, and earlier worked as an equity research analyst at Degroof Petercam. He holds a PhD in Bioengineering from KU Leuven and an MBA from Solvay Brussels School.

Contact· self-published, not guessed

r•••@bioqubeventures.comreveal

Invests in

Biotech

Experience

Bioqube VenturesPartner at Bioqube Venturescurrent2025 — present
Bioqube VenturesPrincipal at Bioqube Ventures2022 — 2025Hasselt, Flemish Region, Belgium
Temmune TherapeuticsBoard Membercurrent2024 — present
Commit BiologicsBoard Membercurrent2022 — present
PMV - Doe- en DurfbedrijfPrincipal Life Sciences & Care2021 — 2022
PMV - Doe- en DurfbedrijfSenior Investment Manager Life Sciences & Care2019 — 2021Brussels, Brussels Region, Belgium
PMV - Doe- en DurfbedrijfInvestment Manager Life Sciences & Care2016 — 2019Brussels, Brussels Region, Belgium
DualyxBoard Member2020 — 2022
miDiagnosticsBoard Member2019 — 2022Leuven
BlueBeeBoard Observer2020 — 2021
Flamingo TherapeuticsBoard Member2020 — 2021
Confo TherapeuticsBoard Member2020 — 2021Ghent, Flemish Region, Belgium
Global Stem cell TechnologyBoard Member2018 — 2019Ghent
Degroof PetercamSell-side analyst Healthcare2012 — 2016Brussels, Brussels Region, Belgium
KU LeuvenPHD Student2007 — 2011Leuven

Skills & more

Banking1Financial Analysis5Investments6Finance2Customer Service1Equities2Project Management2Capital Markets4Corporate Finance2Management1

Languages Dutch · English · French

From Roderick's professional profile.

Investments

Board seats

Aelin TherapeuticsBluebeeConfo TherapeuticsDualyxFlamingo TherapeuticsGSTmiDiagnostics

Per the firm's website.

Colleagues at Bioqube Ventures

Alexander Demoulin

Associate at Bioqube Ventures

Clement Salque

Associate at Bioqube Ventures

Debora Dumont

Managing Partner at Bioqube Ventures

Dirk Reyn

Managing Partner at Bioqube Ventures

Geert Tackaert

Finance Director at Bioqube Ventures

Jacques Mizrahi

Venture Partner at Bioqube Ventures

Janine Schuurman

Senior Advisor at Bioqube Ventures

Jon Edwards

Managing Partner at Bioqube Ventures

Frequently asked questions

Who is Roderick Verhelst?: Partner at Bioqube Ventures focused on early-stage therapeutics, who joined in 2022 with over a decade of life science investing experience, previously at PMV where he helped form, finance and exit startups such as GST, Bluebee, Dualyx and Flamingo Therapeutics, and earlier worked as an equity research analyst at Degroof Petercam. He holds a PhD in Bioengineering from KU Leuven and an MBA from Solvay Brussels School.
Where does Roderick Verhelst work?: Roderick Verhelst is Partner at Bioqube Ventures.
What does Roderick Verhelst invest in?: Roderick Verhelst invests in Biotech.
What check size does Roderick Verhelst write?: Roderick Verhelst typically writes checks of $100K – $5M.
What boards does Roderick Verhelst sit on?: Roderick Verhelst holds tracked board seats at Aelin Therapeutics, Bluebee, Confo Therapeutics, Dualyx, Flamingo Therapeutics, GST, miDiagnostics.
Where did Roderick Verhelst go to school?: Roderick Verhelst studied at Solvay Brussels School of Economics and Management (Master of Business Administration (M.B.A.), Business Administration and Management); KU Leuven (Doctor of Philosophy (Ph.D.), Bioscience Engineering); KU Leuven (Master's Degree, Biochemistry).

Same school

Also attended Solvay Brussels School of Economics and Management64

Jeroen Van IseghemInvestment Analyst at Capricorn Venture Partners Ofir EjnesInvestor at FEBE Ventures Eric van ZuijlenInvestment Partner at E-Capital Equity Management Yannick OswaldPartner at Mangrove Capital Partners Jean-Baptiste MaenhoutInvestment Manager at SmartFin Reginald de WasseigePrincipal at Augmentum Fintech

+ 58 more

Also attended KU Leuven176

Katrin GeyskensExecutive Director at Capricorn Venture Partners Simon WoutersInvestment Manager at Capricorn Venture Partners Steven LambertInvestment Partner Digital at Capricorn Venture Partners Antoine D'HollanderInvestment Director at Capricorn Venture Partners Wouter Van de PutteInvestment Director at Capricorn Venture Partners Filip PintelonInvestment Partner Health at Capricorn Venture Partners

+ 170 more

Shared employers

Also worked at Bioqube Ventures15

Debora DumontManaging Partner at Bioqube Ventures Dirk ReynManaging Partner at Bioqube Ventures Nico VandervelpenManaging Partner at Bioqube Ventures Joris De MaeyerExecutive in Residence at Bioqube Ventures Joris VanderlochtChief Scientific Director at Bioqube Ventures Alexander DemoulinAssociate at Bioqube Ventures

+ 9 more

Also worked at Temmune Therapeutics2

Joris De MaeyerExecutive in Residence at Bioqube Ventures Tom HeymanExecutive Partner at Bioqube Ventures

Also worked at PMV - Doe- en Durfbedrijf8

Herman VerrelstFounding Partner & Senior Advisor at Heran Partners Anne DeGheestMentor Capitalist, Investor & Corporate Advisor at Joyance Partners Thomas BergerBestuurder at Angelwise Christophe BehielsWaarnemer at Angelwise Caroline GoddeerisPartner at Fund+Sophie ManigartLP Committee Chair at Qbic Fund

+ 2 more

Also worked at BlueBee1

Nick RoelofsVenture Partner at Sciety